Search for: "Novartis Pharmaceuticals Corp"
Results 21 - 40
of 366
Sort by Relevance
|
Sort by Date
5 Aug 2021, 12:12 pm
Corp., 785 F.3d 625, 631 (Fed. [read post]
16 Jun 2021, 1:30 pm
New Jersey Tasigna Multi-county Litigation (MCL), Federal Court Tasigna Multidistrict Litigation (MDL) (Posted by Tom Lamb at Drug Injury Watch) In early June 2021, the New Jersey Supreme Court consolidated Tasigna drug injury lawsuits filed against Novartis Pharmaceuticals Corp. before one judge for pretrial proceedings as part of a New Jersey state court multi-county litigation (MCL). [read post]
31 Dec 2020, 7:03 am
Department of Justice announced Novartis AG, a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $300 million in sanctions to resolve FCPA charges for bribery in Greece. [read post]
5 May 2020, 9:37 pm
Novartis Pharmaceuticals Corp. [read post]
3 May 2020, 9:10 pm
Novartis Pharmaceuticals Corp. [read post]
24 Apr 2020, 5:24 am
(collectively, Apotex) filed a petition for inter partes reviewof Novartis Pharmaceuticals Corporation’s U.S. [read post]
3 Mar 2020, 4:00 am
In Novartis Pharmaceuticals Canada Inc. v. [read post]
7 Nov 2019, 8:10 pm
Notable advances include Takeda (up 142% based in part on its Shire acquisition, and jumping in the rankings from 23rd to 17th Q4 2018 – Q1 2019), with several other companies showing robust growth (including Celgene Corp., 37%; Novo Nordisk AS, 17%; Novartis AG, 14%; and Merck KGa, 13%; Hoffmann-La Roche, 12.7%). [read post]
23 May 2019, 3:48 pm
In addition, the defendants targeted the health insurance plans of Medtronic, a medical device company, and Novartis Pharmaceuticals Corp., pharmaceutical company, both known by some of the defendants to have high-reimbursing health insurance. [read post]
16 May 2019, 8:55 pm
Patent No. 8,410,131 were obvious in a decision handed down this week in Novartis Pharmaceuticals Corp. v. [read post]
14 May 2019, 11:24 am
Cir. 2014)(quoting Alza Corp. v. [read post]
18 Apr 2019, 9:43 pm
§ 315(e)(2) filed by Novartis Pharmaceuticals Corp. [read post]
17 Apr 2019, 7:31 am
According to Law360, in late February 2019, a New Jersey jury returned a verdict of over $1.8 million in favor of Min Amy Guo, a whistleblower who alleged that Novartis Pharmaceuticals Corp. terminated her for retaliatory reasons in violation of CEPA. [read post]
15 Apr 2019, 7:19 pm
Timing of Estoppel Unimportant Last week in Novartis Pharmaceutical Corp. v. [read post]
2 Mar 2019, 9:48 pm
Ezra Ventures LLC, Novartis Pharmaceuticals Corp. v. [read post]
20 Dec 2018, 10:14 am
” See Novartis Pharmaceuticals Corp. v. [read post]
11 Dec 2018, 9:46 pm
The first, Novartis AG v. [read post]
18 Oct 2018, 2:30 pm
However this never happened because the following month Novartis Pharmaceuticals Corp. removed Zelnorm from the US market for cardiovascular (CV) safety concerns. [read post]
31 Jul 2018, 9:06 am
We have talked about the FDA’s approval of tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.), a CD19-directed genetically modified autologous T-cell immunotherapy, to include treatment of patients with relapsed or refractory large B-cell lymphoma. [read post]
30 Jun 2018, 2:01 am
Andrews in Novartis Pharmaceuticals Corp. et al. v. [read post]
